1. Home
  2. HRMY vs NTCT Comparison

HRMY vs NTCT Comparison

Compare HRMY & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • NTCT
  • Stock Information
  • Founded
  • HRMY 2017
  • NTCT 1984
  • Country
  • HRMY United States
  • NTCT United States
  • Employees
  • HRMY N/A
  • NTCT N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • NTCT EDP Services
  • Sector
  • HRMY Health Care
  • NTCT Technology
  • Exchange
  • HRMY Nasdaq
  • NTCT Nasdaq
  • Market Cap
  • HRMY 1.9B
  • NTCT 1.6B
  • IPO Year
  • HRMY 2020
  • NTCT 1999
  • Fundamental
  • Price
  • HRMY $26.87
  • NTCT $26.04
  • Analyst Decision
  • HRMY Strong Buy
  • NTCT Buy
  • Analyst Count
  • HRMY 10
  • NTCT 2
  • Target Price
  • HRMY $51.30
  • NTCT $29.00
  • AVG Volume (30 Days)
  • HRMY 1.0M
  • NTCT 606.1K
  • Earning Date
  • HRMY 10-28-2025
  • NTCT 10-23-2025
  • Dividend Yield
  • HRMY N/A
  • NTCT N/A
  • EPS Growth
  • HRMY 58.41
  • NTCT N/A
  • EPS
  • HRMY 3.10
  • NTCT 1.02
  • Revenue
  • HRMY $772,527,000.00
  • NTCT $834,861,000.00
  • Revenue This Year
  • HRMY $19.94
  • NTCT $4.61
  • Revenue Next Year
  • HRMY $16.65
  • NTCT $2.80
  • P/E Ratio
  • HRMY $8.72
  • NTCT $25.60
  • Revenue Growth
  • HRMY 17.74
  • NTCT 5.29
  • 52 Week Low
  • HRMY $26.26
  • NTCT $18.12
  • 52 Week High
  • HRMY $41.61
  • NTCT $27.89
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 27.45
  • NTCT 57.90
  • Support Level
  • HRMY $26.56
  • NTCT $25.46
  • Resistance Level
  • HRMY $27.48
  • NTCT $27.18
  • Average True Range (ATR)
  • HRMY 1.01
  • NTCT 0.52
  • MACD
  • HRMY -0.25
  • NTCT -0.03
  • Stochastic Oscillator
  • HRMY 8.99
  • NTCT 33.92

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: